Italian Medicines Agency Nails Drugmaker for Major Deficiencies

Italian regulators suspended a drugmaker’s marketing authorization following an inspection that revealed multiple serious quality violations at its facility in Cellole—about 30 miles northwest of Naples.
Source: Drug Industry Daily